Mustang Bio Inc. (NASDAQ: MBIO) Stock Information | RedChip

Mustang Bio Inc. (NASDAQ: MBIO) Listen to this Section


$0.38
+0.0034 ( +0.91% ) 2.0M

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Market Data


Open


$0.38

Previous close


$0.38

Volume


2.0M

Market cap


$13.02M

Day range


$0.32 - $0.40

52 week range


$0.13 - $3.78

Insider Ownership Transactions

Total Amount Purchased: -421,736.00 | $ -159,711.42

Date Type Amount Purchased Purchaser
2024-06-04 Sale -1248.00 Litchman Manuel MD
2024-06-04 Sale -1396.00 Litchman Manuel MD
2024-01-03 Sale -419092.00 Fortress Biotech, Inc.

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 72 Aug 13, 2024
def Proxies and info statements 2 Jul 10, 2024
8-k 8K-related 14 Jul 03, 2024
pre Proxies and info statements 2 Jun 28, 2024
8-k 8K-related 13 Jun 06, 2024
4 Insider transactions 1 Jun 04, 2024
4 Insider transactions 1 Jun 04, 2024
8-k 8K-related 13 May 21, 2024
10-q Quarterly Reports 69 May 15, 2024
8-k 8K-related 21 May 02, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.